Vivo Bio Tech Ltd. (VIVOBIOT)
Market Open
11 Aug, 22:00
MSE MSE Primary ₹
21. 75
+0.26
+1.2099%
₹
559.43M Market Cap
14.27 P/E Ratio
- Div Yield
5,742 Volume
0 Eps
₹ 21.49
Previous Close Want to track VIVOBIOT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
VIVOBIOT trading today higher at ₹21.75, an increase of 1.2099% from yesterday's close, completing a monthly increase of 3.2764% or ₹0.69. Over the past 12 months, VIVOBIOT stock lost -31.1709%.
VIVOBIOT is not paying dividends to its shareholders.
The last earnings report, released on May 18, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.2467%, based on the last three reports.
Vivo Bio Tech Ltd. has completed 1 stock splits, with the recent split occurring on Sep 25, 2012.
The company's stock is traded on one exchange.
VIVOBIOT Chart
People also search for
Vivo Bio Tech Ltd. (VIVOBIOT) FAQ
What is the stock price today?
The current price is ₹21.75.
On which exchange is it traded?
Vivo Bio Tech Ltd. is listed on MSE.
What is its stock symbol?
The ticker symbol is VIVOBIOT.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 559.43M.
Has Vivo Bio Tech Ltd. ever had a stock split?
Vivo Bio Tech Ltd. had 1 splits and the recent split was on Sep 25, 2012.
Vivo Bio Tech Ltd. Profile
| Biotechnology Industry | Healthcare Sector | Dr. Alangudi Sankaranarayanan F.C.P., Ph.D. CEO | MSE Exchange | INE380K01017 ISIN |
| India Country | 174 Employees | - Last Dividend | - Last Split | - IPO Date |
Vivo Bio Tech Ltd., a prominent entity in the biotechnology sector, primarily focuses on the research, development, and production of innovative biological products. The company plays a crucial role in the pharmaceutical and healthcare industries by providing specialized services such as contract research and manufacturing. Vivo Bio Tech Ltd. distinguishes itself through its commitment to cutting-edge biotechnological advancements and collaboration with pharmaceutical companies to optimize drug development processes. With a robust infrastructure dedicated to complex biological research, Vivo Bio Tech Ltd. contributes significantly to advancements in medical treatments and therapies, addressing global health challenges. Its operations are integral to the advancement of genetic and molecular biology, impacting areas such as vaccine production, disease diagnostics, and personalized medicine. By leveraging its expertise in biotechnology, Vivo Bio Tech Ltd. aids in the acceleration of new medical solutions, fostering growth within the life sciences sector and reinforcing its importance in the global market.
Contact Information
Address: Illyas Mohammed Khan Estate
Phone: 91 40 2331 3288
Website: https://www.vivobio.com
